Abstract
Free-living amoebae (FLA) rarely cause human infections but can invoke fatal infections in the central nervous system (CNS). No consensus treatment has been established for FLA infections of the CNS, emphasizing the urgent need to discover or develop safe and effective drugs. Flavonoids, natural compounds from plants and plant-derived products, are known to have antiprotozoan activities against several pathogenic protozoa parasites. The anti-FLA activity of flavonoids has also been proposed, while their antiamoebic activity for FLA needs to be emperically determined. We herein evaluated the antiamoebic activities of 18 flavonoids against Naegleria fowleri and Acanthamoeba species which included A. castellanii and A. polyphaga. These flavonoids showed different profiles of antiamoebic activity against N. fowleri and Acanthamoeba species. Demethoxycurcumin, kaempferol, resveratrol, and silybin (A+B) showed in vitro antiamoebic activity against both N. fowleri and Acanthamoeba species. Apigenin, costunolide, (−)-epicatechin, (−)-epigallocatechin, rosmarinic acid, and (−)-trans-caryophyllene showed selective antiamoebic activity for Acanthamoeba species. Luteolin was more effective for N. fowleri. However, afzelin, berberine, (±)-catechin, chelerythrine, genistein, (+)-pinostrobin, and quercetin did not exhibit antiamoebic activity against the amoeba species. They neither showed selective antiamoebic activity with significant cytotoxicity to C6 glial cells. Our results provide a basis for the anti-FLA activity of flavonoids, which can be applied to develope alternative or supplemental therapeutic agents for FLA infections of the CNS.
-
Key words: Naegleria fowleri, Acanthamoeba, flavonoids, antiamoebic activity
Free-living amoebae (FLA) are protozoa that live autonomously in diverse environments, such as soil and fresh water, and feed on bacteria, fungi, and algae. However,
Naegleria fowleri, Balamuthia mandrillaris, and
Acanthamoeba species are pathogenic and can infect humans and cause life-threatening diseases [
1]. Although human infections by these FLA are rare, they can cause rapidly progressive and severe central nervous system (CNS) infections that are almost fatal [
1].
Primary amebic meningoencephalitis (PAM) is a brain infection caused by
Neglaria fowleri. The amoeba enters the brain via the olfactory neuroepithelium and induces an acute hemorrhagic-necrotizing meningoencephalitis accomplished with fulminating inflammation [
2]. The rapid progression of PAM can cause death (mortality rate >97%) within 1 or 2 weeks after the initial exposure [
2].
Acanthamoeba species cause diseases such as acanthamoeba keratitis and granulomatous amebic encephalitis (GAE) in humans [
3]; GAE also has a high lethality of up to 90%, particularly in immunocompromised humans [
3]. Such high fatalities of PAM and GAE are mainly attributed to the lack of a reliable and rapid diagnosis method and effective therapeutic drugs. The currently recommended drug treatment regimens either alone or in combination for PAM and GAE have typically been used for treating bacterial and fungal infections [
2] but provide no guarantee for successful treatment, and undesirable side effects of these drugs are also a concern. Therefore, the development of novel effective drugs for PAM and GAE is urgently required.
Natural compounds from plants have been used to manage or treat diverse diseases throughout human history [
4]. Recently, large screening approaches to find natural compounds with antiamoebic or amoebicidal activity against
N. fowleri and
Acanthamoeba species from diverse natural resources have been performed [
5–
9]. These studies demonstrated the amoebicidal or antiamoebic effects of natural compounds or plant extracts against
N. fowleri and
Acanthamoeba species, suggesting these compounds have potential applications as therapeutic candidates or supplemental compounds for PAM and GAE.
Flavonoids, natural compounds isolated from plants and plant-derived products, have gained attention as attractive alternative drugs or leads for protozoan parasites such as
Entamoeba histolytica,
Giardia intestinalis,
Cryptosporidium parvum, and
Trypanosoma cruzi [
10–
13]. Several flavonoids have recently been proposed as potential candidates for anti-FLA drug development based on these studies [
14]. However, their antiamoebic activity for FLA has not yet been experimentally determined. Herein, we evaluated the antiamoebic activity of selected flavonoids against trophozoites of
N. fowleri and
Acanthamoeba species.
Based on a literature review [
10,
14], a selection of 18 flavonoids was made according to their potential antiprotozoan activities on other protozoan parasites and included (−)-epicatechin, (−)-epigallocatechin, (±)-catechin hydrate, demethoxycurcumin, luteolin, resveratrol, silybin (A+B) mixture, rosmarinic acid, (−)-trans-caryophyllene, costunolide, kaempferol, apigenin, afzelin, quercetin, genistein, berberine, chelerythrine chloride, and (+)-pinostrobin. Azithromycin dihydrate and miltefosine were included as control drugs. All flavonoids and chemicals were purchased from Sigma (St. Louis, MO, USA) and dissolved in dimethyl sulfoxide (DMSO; Sigma) or distilled water at 100 mM. The purity of all flavonoids was >95%.
Neglaria fowleri (Carter NF69 strain, ATCC 30215) trophozoites were cultured and maintained in Nelson’s medium containing 5% fetal bovine serum (Gibco, Grand Island, NY, USA) and 1% penicillin/streptomycin (Gibco) at 37°C. A. castellanii (ATCC-30868) and A. polyphaga (ATCC-30461) were axenically cultured and maintained in peptone-yeast-glucose medium supplemented with 1% penicillin/streptomycin at 25°C.
C6 rat glial cells (ATCC CCL-107) were cultured in Dulbecco’s modified Eagle medium (Gibco) supplemented with 10% fetal bovine serum (Gibco) and 1% penicillin/streptomycin (Gibco) at 37°C in a humidified 5% CO2 incubator.
Neglaria fowleri trophozoites (5×104 cells/well) were seeded on 96-well microplates (Thermo Fisher Scientific, Waltham, MA, USA) in Nelson’s medium and incubated at 37°C overnight. A. castellanii and A. polyphaga trophozoites (5×104 cells/well) were seeded on 96-well microplates (Thermo Fisher Scientific) in peptone-yeast-glucose medium and incubated at 25°C overnight. Different concentrations (0–400 μM) of each flavonoid were used to treat N. fowleri and Acanthamoeba trophozoites followed by incubation at 37°C or 25°C for 48 h, respectively. Azithromycin and miltefosine were included as control drugs with the same procedures. Morphological changes of the amoebae were observed microscopically every 12 h. The viability of the amoebae was accessed with a colorimetric method using the CellTiter-Blue Cell viability assay (Promega, Madison, WI, USA). All experiments were performed in triplicate with 3 replicates. Data are presented as mean±standard deviation (SD) of 3 independent experiments. The inhibitory concentration 50 (IC50) of each compound was calculated using GraphPad Prism 9.1.0 software (GraphPad Software, San Diego, CA, USA). Amoebae treated with 0.1% DMSO were used as negative controls, representing 100% cell viability.
The potential cytotoxicity of each flavonoid against C6 glial cells was analyzed. Cells were seeded in 96-well microplates (Thermo Fisher Scientific; 2×104 cells/well) and incubated overnight until 80% confluence. Serially diluted flavonoids (0–400 μM) or control drugs were used to treat cells as described above. Morphological alterations of the cells were observed via microscopic examination. Cell viability was determined using the CellTiter-Blue Cell viability assay (Promega). All experiments were performed in triplicate with 3 replicates. Data are given as mean±SD of 3 independent assays. The cytotoxicity concentration 50 (CC50) of each flavonoid was calculated using GraphPad Prism 9.1.0 software (GraphPad Software). The sensitivity index (SI) was determined by the ratio between CC50 and IC50. Cells treated with 0.1% DMSO, which was confirmed not to induce the morphological change of the cells under microscopic examination, were used as controls with 100% cell viability.
In vitro anti-
N. fowleri activities of 18 flavonoids were evaluated by incubating the amoeba with various concentrations of each flavonoid. Six of the 18 flavonoids showed anti-
N. fowleri activity with IC
50 values <50 μM (
Table 1). Demethoxycurcumin, luteolin, and kaempferol had low IC
50 values <30 μM and high SI values >7 and was more effective than miltefosine, a reference drug. Resveratrol and silybin (A+B) also showed low IC
50 against
N. fowleri but displayed partial effects on C6 glial cells, producing lower SI values of 4.68 and 4.13, respectively. Chelerythrine had the most robust antiamoebic activity against
N. fowleri (IC
50=11.83±1.15 μM) but showed potent cytotoxicity against C6 glial cells, producing low CC
50 and SI values. The other 12 flavonoids showed weak anti-
N. fowleri activity (IC
50 >65 μM) and low SI values (<4).
The in vitro anti-
Acanthamoeba activity of the flavonoids was analyzed. The IC
50 values of the flavonoids slightly differed by
Acanthamoeba species, and
A. polyphaga was generally more sensitive than
A. castellanii. Among the 18 flavonoids, 10 showed antiamoebic activity against
A. castellanii and
A. polyphaga (
Table 1). (−)-Epicatechin, (−)-epigallocatechin, demethoxycurcumin, apigenin, resveratrol, rosmarinic acid, silybin (A+B), costunolide, and kaempferol had low IC
50 <50 μM for both
Acanthamoeba species. In particular, (−)-epicatechin, (−)-epigallocatechin, demethoxycurcumin, rosmarinic acid, and kaempferol displayed high SI values >8. Apigenin, resveratrol, silybin (A+B), costunolide, and (−)-trans-caryophyllene also showed potential antiamoebic activity against
Acanthamoeba but also partially affected C6 glial cells, producing relatively low CC
50 and SI values. Luteolin was effective only for
A. polyphaga. The other seven flavonoids, (±)-catechin, afzelin, quercetin, genistein, berberine, chelerythrine, and (+)-pinostrobin, did not exhibit potential or selective antiamoebic activity against either
Acanthamoeba species.
The 18 flavonoids showed different profiles of antiamoebic activity against
N. fowleri and
Acanthamoeba species. However, demethoxycurcumin and kaempferol showed promising in vitro antiamoebic activity against both
N. fowleri and
Acanthamoeba species with low IC
50 values (<40 μM) and high SI values (>8). The overlapping antiamoebic activities of demethoxycurcumin and kaempferol against both
N. fowleri and
Acanthamoeba species suggest these flavonoids could be candidates for drug development for both PAM and GAE. Resveratrol and silybin (A+B) also showed reasonable IC
50 and SI values against both
N. fowleri and
Acanthamoeba species. The antiamoebic activities of kaempferol, demethoxycurcumin, and resveratrol have been reported previously. Kaempferol was shown to block the proliferation and invasion of
E. histolytica trophozoites in vitro through the degradation of the cytoskeleton [
15] and to induce programmed cell death in
N. fowleri [
16]. Demethoxycurcumin and resveratrol were toxic to
A. castellanii trophozoites and inhibited the binding of the trophozoites to host cells [
17]. These studies support the hypothesis that these flavonoids are attractive candidates for anti-FLA drug development. However, further investigations are necessary to understand the underlying antiamoebic mechanisms of these flavonoids at the molecular level and evaluate their biosafety.
The anti-
Acanthamoeba activities of (−)-epicatechin, (−)-epigallocatechin, apigenin, and rosmarinic acid have been partially reported [
7,
10,
18]. Consistent with these studies, we confirmed the anti-
Acanthamoeba activities of these 4 flavonoids herein, although they did not show significative anti-
N. fowleri activities. Interestingly, these flavonoids had different IC
50 values against
A. castellanii and
A. polyphaga, suggesting further investigation is required on these inconsistent antiamoebic activities against different
Acanthamoeba species and underlying molecular mechanisms of these flavonoids for anti-
Acanthamoeba activities.
Apigenin and luteolin reportedly show potential cytotoxicity against murine macrophages J774A.1 but did induce programmed cell death in
A. castellanii [
7]. However, the 2 flavones did not show significative cytotoxicity to C6 glial cells in our study, suggesting further evaluation is needed of these flavones as potential anti-
Acanthamoeba drug candidates. The antiamoebic activity of luteolin is also a novel finding obtained in this study. Luteolin showed promising IC
50 values (<30 μM) and high SI values (>11) for
N. fowleri and
A. polyphaga, implying substantial and selective antiamoebic activity without toxicity to animal cells but was not effective against
A. castellanii. Further studies are therefore required to investigate the molecular mechanism of the antiamoebic activity of luteolin and evaluate its effectiveness as a drug candidate.
A recent in silico analysis demonstrated that chelerythrine and berberine are attractive drug candidates for PAM [
19], and the strong antiamoebic activity of chelerythrine against
N. fowleri was confirmed in this study to support the in silico results. However, chelerythrine also showed strong toxicity to C6 glial cells, producing very low CC
50 and SI values. Considering the high antiamoebic activity of the alkaloid for the
N. fowleri, studies using derivatives of chelerythrine should be performed to reduce the toxicity to human cells. Berberine did not affect either
N. fowleri or
Acanthamoeba species.
In addition to the 18 flavonoids evaluated in this study, flavonoids such as anemonin, conessine, curcumin, isotrilobine, mangostin, and quassin have been proposed as potential candidates with anti-FLA activities because of their known antiamoebic activities for
E. histolytica [
14]. Further analyses of the anti-FLA activities of these flavonoids would be interesting in drug repurposing.
In conclusion, we experimentally confirmed that 11 flavonoids possess antiamoebic activities against
N. fowleri and
Acanthamoeba species. These flavonoids exhibited different antiamoebic profiles against the amoeba species and can be applied as alternative or supplement therapeutic agents to treat PAM and GAE. Further studies to determine the molecular mechanisms of the antiamoebic activities of these flavonoids and in vivo studies to evaluate their clinical significances are necessary. Significant variances in drug susceptibility among
N. fowleri strains and isolates have also been reported [
20], suggesting that additional studies to evaluate the antiamoebic activity of flavonoids for different genotypes or clinical isolates of the amoeba are also required. Moreover, studies to evaluate the antiamoebic activity of flavonoids, alone or in combination with other drugs, are recommended to support the design or formulation of effective treatment regimens.
Notes
-
Author contributions
Conceptualization: Lê HG, Na BK
Data curation: Lê HG
Formal analysis: Lê HG, Võ TC, Kang JM, Nguyễn TH, Hwang BS, Oh YT, Na BK
Funding acquisition: Lê HG, Na BK, Oh YT
Investigation: Lê HG, Na BK
Methodology: Lê HG
Project administration: Lê HG, Na BK, Oh YT
Supervision: Na BK
Validation: Võ TC, Kang JM, Na BK
Writing– original draft: Lê HG, Na BK
Writing– review & editing: Lê HG, Võ TC, Kang JM, Nguyễn TH, Hwang BS, Oh YT, Na BK
-
The authors declare no conflict of interest.
Acknowledgments
This research was supported by the National Research Foundation of Korea (NRF) grants from the Government of Korea (NRF-2021R1A2C109185513 and RS-2023-00237240) and by the Nakdonggang National Institute of Biological Resource (NNIBR202303105) grant funded by the Ministry of Environment of the Republic of Korea.
Table 1Anti-amoebic activities of flavonoids against N. fowleri and Acanthamoeba species
Table 1
|
Classification |
Compounds |
N. fowleri (IC50 ±SD, μM) |
A. castellanii (IC50 ±SD, μM) |
A. polyphaga (IC50 ±SD, μM) |
C6 glial cells (CC50 ±SD, μM) |
SIb
|
SIc
|
SId
|
|
Flavan-3-ols (Flavanols) |
(−)-Epicatechin |
102.62±0.97 |
33.38±0.68 |
25.02±0.14 |
318.62±0.82 |
3.11 |
9.55 |
12.73 |
|
(−)-Epigallocatechin |
114.59±0.48 |
32.14±1.03 |
24.16±0.16 |
278.98±0.30 |
2.44 |
8.68 |
11.55 |
|
(±)-Catechin |
>344.51 |
>344.51 |
>344.51 |
>344.51 |
- |
- |
- |
|
|
Beta-diketone |
Demethoxycurcumina
|
27.07±0.35 |
36.09±0.82 |
21.93±0.18 |
>295.55 |
>11.10 |
>8.19 |
>13.48 |
|
|
Flavones |
Luteolin |
27.45±0.61 |
>350.21 |
40.23±0.47 |
>350.21 |
>12.72 |
- |
>8.71 |
|
Apigenin |
94.65±0.58 |
43.39±0.80 |
28.33±0.13 |
243.09±0.98 |
2.57 |
5.60 |
8.58 |
|
|
Polyphenols |
Resveratrola
|
47.19±0.36 |
40.03±0.39 |
31.35±0.08 |
220.78±0.09 |
4.68 |
5.52 |
7.04 |
|
Rosmarinic acid |
77.69±0.97 |
31.66±0.31 |
22.41±0.78 |
>277.54 |
>3.57 |
>8.77 |
>12.38 |
|
|
Flavonolignans |
Silybin (A+B)a
|
24.20±0.27 |
24.46±0.56 |
15.82±0.06 |
99.89±0.78 |
4.13 |
4.08 |
6.31 |
|
|
Sesquiterpene |
Costunolide |
65.56±0.58 |
32.02±1.14 |
35.14±0.74 |
191.19±1.18 |
2.92 |
5.97 |
5.44 |
|
(−)-trans-Caryophyllene |
84.78±0.65 |
65.06±1.42 |
44.77±1.41 |
220.36±2.42 |
2.60 |
3.39 |
4.92 |
|
|
Flavonols |
Kaempferola
|
27.82±0.33 |
21.63±1.28 |
28.61±1.17 |
333.82±0.99 |
12.00 |
15.43 |
11.67 |
|
Afzelin |
>230 |
>230 |
>230 |
>230 |
- |
- |
- |
|
Quercetin |
>330 |
>330 |
320.81±0.33 |
>330 |
- |
- |
>1.03 |
|
|
Isoflavonoids |
Genistein |
157.38±0.57 |
>370 |
>370 |
103.93±1.08 |
0.66 |
- |
- |
|
|
Alkaloid |
Berberine |
>260 |
>260 |
>260 |
159.65±1.23 |
- |
- |
- |
|
Chelerythrine |
11.83±1.15 |
148.10±1.38 |
101.89±1.40 |
16.43±0.45 |
1.39 |
- |
- |
|
|
Flavonoid |
(+)-Pinostrobin |
>370 |
>370 |
>370 |
>370 |
- |
- |
- |
|
|
Antibiotics |
Azithromycin |
14.67±1.65 |
12.11±0.20 |
4.12±0.11 |
86.24±0.93 |
5.88 |
7.12 |
20.93 |
|
|
Chemical |
Miltefosine |
153.34±1.30 |
213.23±1.22 |
227.45±0.36 |
>245 |
>1.60 |
>1.15 |
>1.08 |
References
- 1. Sarink MJ, van der Meijs NL, Denzer K, Koenderman L, Tielens AGM, et al. Three encephalitis-causing amoebae and their distinct interactions with the host. Trends Parasitol 2022;38(3):230-245.
https://doi.org/10.1016/j.pt.2021.10.004
- 2. Grace E, Asbill S, Virga K.
Naegleria fowleri: pathogenesis, diagnosis, and treatment options. Antimicrob Agents Chemother 2015;59(11):6677-6681.
https://doi.org/10.1128/aac.01293-15
- 3. Visvesvara GS, Moura H, Schuster FL. Pathogenic and opportunistic free-living amoebae: Acanthamoeba spp., Balamuthia mandrillaris, Naegleria fowleri, and Sappinia diploidea
. FEMS Immunol Med Microbiol 2007;50(1):1-26.
https://doi.org/10.1111/j.1574-695x.2007.00232.x
- 4. Clardy J, Walsh C. Lessons from natural molecules. Nature 2004;432(7019):829-837.
https://doi.org/10.1038/nature03194
- 5. Sangkanu S, Mitsuwan W, Mahabusarakam W, Jimoh TO, Wilairatana P, et al. Anti-Acanthamoeba synergistic effect of chlorhexidine and Garcinia mangostana extract or α-mangostin against Acanthamoeba triangularis trophozoite and cyst forms. Sci Rep 2021;11(1):8053.
https://doi.org/10.1038/s41598-021-87381-x
- 6. Mitsuwan W, Sangkanu S, Romyasamit C, Kaewjai C, Jimoh TO, et al.
Curcuma longa rhizome extract and curcumin reduce the adhesion of Acanthamoeba triangularis trophozoites and cysts in polystyrene plastic surface and contact lens. Int J Parasitol Drugs Drug Resist 2020;14:218-229.
https://doi.org/10.1016/j.ijpddr.2020.11.001
- 7. Sifaoui I, López-Arencibia A, Martín-Navarro CM, Reyes-Batlle M, Wagner C, et al. Programmed cell death in Acanthamoeba castellanii Neff induced by several molecules present in olive leaf extracts. PLoS One 2017;12(8):e0183795.
https://doi.org/10.1371/journal.pone.0183795
- 8. Lê HG, Choi JS, Hwang BS, Jeong YT, Kang JM, et al.
Phragmites australis (Cav.) Trin. ex Steud. extract induces apoptosis-like programmed cell death in Acanthamoeba castellanii trophozoites. Plants 2022;11(24):3459.
https://doi.org/10.3390/plants11243459
- 9. Belofsky G, Carreno R, Goswick SM, John DT. Activity of isoflavans of Dalea aurea (Fabaceae) against the opportunistic ameba Naegleria fowleri
. Planta Med 2006;72(4):383-386.
https://doi.org/10.1055/s-2005-916252
- 10. Martínez-Castillo M, Pacheco-Yepez J, Flores-Huerta N, Guzmán-Téllez P, Jarillo-Luna RA, et al. Flavonoids as a natural treatment against Entamoeba histolytica
. Front Cell Infect Microbiol 2018;8:209.
https://doi.org/10.3389/fcimb.2018.00209
- 11. Barbosa H, Thevenard F, Quero Reimão J, Tempone AG, Honorio KM, et al. The potential of secondary metabolites from plants as drugs or leads against Trypanosoma cruzi-an update from 2012 to 2021. Curr Top Med Chem 2022;23(3):159-213.
https://doi.org/10.2174/1568026623666221212111514
- 12. Ticona JC, Bilbao-Ramos P, Amesty Á, Flores N, Dea-Ayuela MA, et al. Flavonoids from piper species as promising antiprotozoal agents against Giardia intestinalis: structure-activity relationship and drug-likeness studies. Pharmaceuticals 2022;15(11):1386.
https://doi.org/10.3390/ph15111386
- 13. Mead JR, McNair N. Antiparasitic activity of flavonoids and isoflavones against Cryptosporidium parvum and Encephalitozoon intestinalis
. FEMS Microbiol Lett 2006;259(1):153-157.
https://doi.org/10.1111/j.1574-6968.2006.00263.x
- 14. Siddiqui R, Yehia Abouleish M, Khamis M, Ibrahim T, Khan NA. Current medicines hold promise in the treatment of orphan infections due to brain-eating amoebae. Expert Opin Orphan Drugs 2021;9(11–12):227-235.
https://doi.org/10.1080/21678707.2021.2050368
- 15. Bolaños V, Díaz-Martínez A, Soto J, Marchat LA, Sanchez-Monroy V, et al. Kaempferol inhibits Entamoeba histolytica growth by altering cytoskeletal functions. Mol Biochem Parasitol 2015;204(1):16-25.
https://doi.org/10.1016/j.molbiopara.2015.11.004
- 16. Lê HG, Kang JM, Võ TC, Na BK. Kaempferol induces programmed cell death in Naegleria fowleri.
. Phytomedicine 2023;119:154994.
https://doi.org/10.1016/j.phymed.2023.154994
- 17. Aqeel Y, Iqbal J, Siddiqui R, Gilani AH, Khan NA. Anti-Acanthamoebic properties of resveratrol and demethoxycurcumin. Exp Parasitol 2012;132(4):519-523.
https://doi.org/10.1016/j.exppara.2012.09.007
- 18. Fakae LB, Harun MSR, Ting DSJ, Dua HS, Cave GWV, et al.
Camellia sinensis solvent extract, epigallocatechin gallate and caffeine confer trophocidal and cysticidal effects against Acanthamoeba castellanii.
. Acta Trop 2023;237:106729.
https://doi.org/10.1016/j.actatropica.2022.106729
- 19. Abraham J, Chauhan N, Ray S. Virtual screening of alkaloid and terpenoid inhibitors of SMT expressed in Naegleria sp
. Molecules 2022;27(17):5727.
https://doi.org/10.3390/molecules27175727
- 20. Russell AC, Kyle DE. Differential growth rates and in vitro drug susceptibility to currently used drugs for multiple isolates of Naegleria fowleri
. Microbiol Spectr 2022;10(1):e0189921.
https://doi.org/10.1128/spectrum.01899-21
, Tuấn Cường Võ1,2
